These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1240 related articles for article (PubMed ID: 28486704)

  • 1. Cost-effectiveness analysis of lifestyle intervention in obese infertile women.
    van Oers AM; Mutsaerts MAQ; Burggraaff JM; Kuchenbecker WKH; Perquin DAM; Koks CAM; van Golde R; Kaaijk EM; Schierbeek JM; Klijn NF; van Kasteren YM; Land JA; Mol BWJ; Hoek A; Groen H;
    Hum Reprod; 2017 Jul; 32(7):1418-1426. PubMed ID: 28486704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of lifestyle intervention in subgroups of obese infertile women: a subgroup analysis of a RCT.
    van Oers AM; Groen H; Mutsaerts MA; Burggraaff JM; Kuchenbecker WK; Perquin DA; Koks CA; van Golde R; Kaaijk EM; Schierbeek JM; Oosterhuis GJ; Broekmans FJ; Vogel NE; Land JA; Mol BW; Hoek A;
    Hum Reprod; 2016 Dec; 31(12):2704-2713. PubMed ID: 27798042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifestyle intervention prior to IVF does not improve embryo utilization rate and cumulative live birth rate in women with obesity: a nested cohort study.
    Wang Z; Groen H; Van Zomeren KC; Cantineau AEP; Van Oers A; Van Montfoort APA; Kuchenbecker WKH; Pelinck MJ; Broekmans FJM; Klijn NF; Kaaijk EM; Mol BWJ; Hoek A; Van Echten-Arends J
    Hum Reprod Open; 2021; 2021(4):hoab032. PubMed ID: 34557597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotrophins versus clomiphene citrate with or without IUI in women with normogonadotropic anovulation and clomiphene failure: a cost-effectiveness analysis.
    Bordewijk EM; Weiss NS; Nahuis MJ; Bayram N; van Hooff MHA; Boks DES; Perquin DAM; Janssen CAH; van Golde RJT; Lambalk CB; Goddijn M; Hompes PG; van der Veen F; Mol BWJ; van Wely M;
    Hum Reprod; 2019 Feb; 34(2):276-284. PubMed ID: 30576539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight reduction intervention for obese infertile women prior to IVF: a randomized controlled trial.
    Einarsson S; Bergh C; Friberg B; Pinborg A; Klajnbard A; Karlström PO; Kluge L; Larsson I; Loft A; Mikkelsen-Englund AL; Stenlöf K; Wistrand A; Thurin-Kjellberg A
    Hum Reprod; 2017 Aug; 32(8):1621-1630. PubMed ID: 28854592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resumption of ovulation in anovulatory women with PCOS and obesity is associated with reduction of 11β-hydroxyandrostenedione concentrations.
    Wang Z; Van Faassen M; Groen H; Cantineau AEP; Van Oers A; Van der Veen A; Hawley JM; Keevil BG; Kema IP; Hoek A
    Hum Reprod; 2024 May; 39(5):1078-1088. PubMed ID: 38503490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women.
    Le KD; Vuong LN; Ho TM; Dang VQ; Pham TD; Pham CT; Norman RJ; Mol BWJ
    Hum Reprod; 2018 Oct; 33(10):1907-1914. PubMed ID: 30239784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hysterosalpingo-foam sonography versus hysterosalpingography during fertility work-up: an economic evaluation alongside a randomized controlled trial.
    Kamphuis D; van Eekelen R; van Welie N; Dreyer K; van Rijswijk J; van Hooff MHA; de Bruin JP; Verhoeve HR; Mol F; van Baal WM; Traas MAF; van Peperstraten AM; Manger AP; Gianotten J; de Koning CH; Koning AMH; Bayram N; van der Ham DP; Vrouenraets FPJM; Kalafusova M; van de Laar BIG; Kaijser J; Lambeek AF; Meijer WJ; Broekmans FJM; Valkenburg O; van der Voet LF; van Disseldorp J; Lambers MJ; Tros R; Lambalk CB; Stoker J; van Wely M; Bossuyt PMM; Mol BWJ; Mijatovic V
    Hum Reprod; 2024 Jun; 39(6):1222-1230. PubMed ID: 38600625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of endometrial scratching before the second IVF/ICSI treatment: a cost-effectiveness analysis of a randomized controlled trial (SCRaTCH trial).
    van Hoogenhuijze NE; van Eekelen R; Mol F; Schipper I; Groenewoud ER; Traas MAF; Janssen CAH; Teklenburg G; de Bruin JP; van Oppenraaij RHF; Maas JWM; Moll E; Fleischer K; van Hooff MHA; de Koning CH; Cantineau AEP; Lambalk CB; Verberg M; van Heusden AM; Manger AP; van Rumste MME; van der Voet LF; Pieterse QD; Visser J; Brinkhuis EA; den Hartog JE; Glas MW; Klijn NF; van der Zanden M; Bandell ML; Boxmeer JC; van Disseldorp J; Smeenk J; van Wely M; Eijkemans MJC; Torrance HL; Broekmans FJM
    Hum Reprod; 2022 Jan; 37(2):254-263. PubMed ID: 34864993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of 'immediate IVF' versus 'delayed IVF': a prospective study.
    Eijkemans MJC; Kersten FAM; Lintsen AME; Hunault CC; Bouwmans CAM; Roijen LH; Habbema JDF; Braat DDM
    Hum Reprod; 2017 May; 32(5):999-1008. PubMed ID: 28204519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
    Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
    Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
    Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
    van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative live birth rates in low-prognosis women.
    Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; van Golde RJT; Hoek A; Lambalk CB; de Bruin JP; Fleischer K; Mochtar MH; Kuchenbecker WKH; Laven JSE; Mol BWJ; Torrance HL; Broekmans FJM;
    Hum Reprod; 2019 Jun; 34(6):1030-1041. PubMed ID: 31125412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder.
    van Tilborg TC; Torrance HL; Oudshoorn SC; Eijkemans MJC; Koks CAM; Verhoeve HR; Nap AW; Scheffer GJ; Manger AP; Schoot BC; Sluijmer AV; Verhoeff A; Groen H; Laven JSE; Mol BWJ; Broekmans FJM;
    Hum Reprod; 2017 Dec; 32(12):2496-2505. PubMed ID: 29121326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expectant management versus IUI in unexplained subfertility and a poor pregnancy prognosis (EXIUI study): a randomized controlled trial.
    Wessel JA; Mochtar MH; Besselink DE; Betjes H; de Bruin JP; Cantineau AEP; Groenewoud ER; Hooker AB; Lambalk CB; Kwee J; Kaaijk EM; Louwé LA; Maas JWM; Mol BWJ; van Rumste MME; Traas MAF; Goddijn M; van Wely M; Mol F
    Hum Reprod; 2022 Nov; 37(12):2808-2816. PubMed ID: 36331493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term prognosis for live birth in couples initiating fertility treatments.
    Malchau SS; Henningsen AA; Loft A; Rasmussen S; Forman J; Nyboe Andersen A; Pinborg A
    Hum Reprod; 2017 Jul; 32(7):1439-1449. PubMed ID: 28472455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of switching to gonadotrophins versus continuing with clomiphene citrate, with or without intrauterine insemination, in women with normogonadotropic anovulation and clomiphene failure: follow-up study of a factorial randomized clinical trial.
    Bordewijk EM; Jannink TI; Weiss NS; de Vries T; Nahuis M; Hoek A; Goddijn M; Mol BW; van Wely M;
    Hum Reprod; 2023 Mar; 38(3):421-429. PubMed ID: 36622200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dropout is a problem in lifestyle intervention programs for overweight and obese infertile women: a systematic review.
    Mutsaerts MA; Kuchenbecker WK; Mol BW; Land JA; Hoek A
    Hum Reprod; 2013 Apr; 28(4):979-86. PubMed ID: 23427235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.